laboration with the Royal College of Radiologists.5 This refreshingly clear and concise report emphasises the vital part that nuclear medicine now plays in good medical practice and recommends that facilities should be made available in all district general hospitals if optimal medical care is to be available uniformly throughout the country.
Facilities should be centralised under a properly trained clinician, who should have spent two years' training in a recognised department, says the report. It considers he should give about half his time to the specialty and be either a general physician, who could encompass the whole range of nuclear medicine techniques, or a radiologist, who would supervise nuclear medicine imaging and who would be well placed to integrate this with both old and the newer radiological methods and with ultrasound. In both instances help from non-medical scientists would be needed, not necessarily all on site. The intercollegiate report also gives sensible advice on training and accreditation of the clinician and-thank goodness-considers that no new examination is needed in nuclear medicine.
Financial restraints will make all this difficult to implement, as they have done for a decade, but nevertheless the report points out (and several precise financial details are given) that the cost of these services is comparable with conventional radiological techniques and considerably cheaper than others, such as computed tomography and coronary angiography.
No practising physician or surgeon would deny the need for such a service in every district general hospital. There seems to be a place, however, for more flexibility than envisaged in this report. The whole range of nuclear medicine services is now available in most of the tcaching centres in Britain, but in some these are fragmented and not yet under the direction of a fully trained consultant. This can be rectified as the present directors, mostly non-medical scientists, retire. Nevertheless, a similar comprehensive service is needed in all the other major medical centres, mostly in cities. These usually have a radiotherapy centre and other subregional specialties and ideally what they now need is a clinician who would give substantially all his time to nuclear medicine. Such fully committed consultants would require four years' training in the specialty as envisaged in this and the earlier intercollegiate report.
In district general hospitals in smaller towns, by contrast, a radiologist trained in nuclear medicine would be the better option. In these hospitals there is no reason why simple non-imaging function tests and radioimmunoassay measurements should not continue to be performed in other laboratories. These and the imaging service could be supported by the nearest comprehensive centre, a theme originally suggested by the Windeyer report but only hinted at in the last intercollegiate report.
With such a scheme the nuclear medicine consultant in the major centre could help his colleagues by providing general guidance and skill, arrange regular clinical meetings, and perform the more elaborate investigations. Physicists would advise on equipment and its management and give authoritative guidance on radiation protection-something that constantly worries technicians and nurses handling the smallest quantities of radionuclides. The comprehensive centre could also provide supplies of less often used and more expensive radiopharmaceuticals and give other help from the radiopharmacist. Indeed, in some instances all the non-medical scientists and technicians might be based on and be interchangeable with their counterparts at the major centre.
The continuing failure by the DHSS to implement the sensible recommendations of these intercollegiate reports is largely due to financial restraints related to the strategic philosophy of the National Health Service in the past 10 years. Much is also due, however, to the hand to mouth manner in which the NHS is run, with its rigid establishments and failure to welcome the numerous advances in medical science. Whereas in a proper "service" a suitable clinician would be specifically chosen and seconded for training, this does not happen in the NHS, certainly not in district general hospitals.
It is all the more important, therefore, for hospital and regional medical committees to foresee the need for a specialist in nuclear medicine some time before the next retirement is due, and to plan accordingly. And let us hope that in a few years this important specialty, which has now come of age, will be fully integrated into NHS hospitals-and that further intercollegiate reports will be unnecessary. The finding of precipitating antibody in a patient's serum is not necessarily an indication that his symptoms are due to allergic alveolitis. About 40%0 of symptomless pigeon breeders have antibodies,5 6 and the frequency of antibodies increases with the duration and intensity of exposure. The strength of the antigen-antibody reaction is as great in some symptomless breeders as in people with the disease.5
Nor are bird droppings the only source of antigen. Pigeon feathers have a waxy coating called bloom, which comes off on the hands. Precipitins against bloom extract have been found in 60% of fanciers, and only 40%0 of these had precipitins against pigeon serum.6 The mean antibody concentration to bloom extract was higher in those suspected of disease than in the symptomless, but the high frequency of precipitins suggests that it is even less discriminating than pigeon serum.
In keepers of budgerigars a positive precipitin test is usually considered to be an indicator of disease3; this is fortunate because their symptoms are insidious and less characteristic. Support for this view, however, is not widely documented, and in one series alveolitis was diagnosed in only 56% of people with precipitins.7
Considerable cross reaction occurs in precipitin tests with different avian species. Sixty per cent of human sera containing antibody against one species, mainly pigeon, also reacted with all the other species tested including budgerigar, canary, sparrow, blackbird, finch, and hen.4 In only one instance out of 40 was there a reaction to a single antigen. The clinical corollary is that a person with allergic alveolitis caused by one kind of bird may get identical symptoms when exposed to another species with which he is not usually in contact.8
Another factor which may explain the lack of specificity of the precipitin test is that the disease is not mediated by a type 3 reaction alone. Cell mediated hypersensitivity (type 4) plays a part,9 10 and lymphocyte transformation may be a more specific indicator of disease than the precipitin test.
Intradermal tests with bird serum usually produce characteristic dual reactions,"1 but these are not often used, probably because antigen is not easily available. 
